|
Market Closed -
Nasdaq
01:30:00 03/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 10.50 USD | -6.75% |
|
-10.79% | -33.04% |
| 01/10 | Monte Rosa Therapeutics Announces Positive Data From GFORCE-1 Phase 1 Study Evaluating MRT-8102 | CI |
| 01/10 | Monte Rosa Therapeutics, Inc. - Special Call |
| Market Cap | 90Cr 80Cr 74Cr 68Cr 127.7Cr 8.61TCr 128.89Cr 898.98Cr 348.36Cr 4.4TCr 336.32Cr 329.02Cr 14TCr | P/E 2026 * |
-7.1x | P/E 2027 * | -5.34x |
|---|---|---|---|---|---|
| Enterprise Value | 90Cr 80Cr 74Cr 68Cr 127.7Cr 8.61TCr 128.89Cr 898.98Cr 348.36Cr 4.4TCr 336.32Cr 329.02Cr 14TCr | EV / Sales 2026 * |
13.3x | EV / Sales 2027 * | 16.6x |
| Free-Float |
99.44% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GLUE | Delayed | |
CBOE
| GLUE | Real-time |
Last Transcript: Monte Rosa Therapeutics, Inc.
| 1 day | -6.75% | ||
| 1 week | -10.79% | ||
| Current month | -11.99% | ||
| 1 month | -26.16% | ||
| 3 months | -56.63% | ||
| 6 months | -38.56% | ||
| Current year | -33.04% |
| 1 week | 10.32 |  | 12.26 |
| 1 month | 10.32 | | 14.87 |
| Current year | 10.32 | | 25.77 |
| 1 year | 7.24 | | 25.77 |
| 3 years | 2.44 | | 25.77 |
| 5 years | 2.44 | | 27.56 |
| 10 years | 2.44 | | 45.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Markus Warmuth
CEO | Chief Executive Officer | 55 | 01/01/2020 |
Magnus Walter
CTO | Chief Tech/Sci/R&D Officer | - | 17/03/2026 |
| Chief Operating Officer | 54 | 01/03/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Markus Warmuth
BRD | Director/Board Member | 55 | 01/01/2020 |
Ali Behbahani
BRD | Director/Board Member | 49 | 01/04/2020 |
| Director/Board Member | 57 | 01/06/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/07/26 | Sell | Chief Executive Officer | -9,500 | 0.0112% | ||
| 15/07/26 | Exercice | Chief Operating Officer | 13,053 | 0.0155% | ||
| 06/07/26 | Exercice | Chief Technology Officer | 18,000 | 0.0213% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.75% | -10.79% | +37.61% | +132.30% | 90Cr | |
| +4.16% | +3.04% | +49.37% | +94.17% | 7.42TCr | |
| -3.11% | -3.53% | +21.92% | +74.60% | 5.74TCr | |
| +0.89% | -0.63% | +4.28% | +34.51% | 4.76TCr | |
| +0.36% | +0.81% | +352.17% | +689.61% | 4.43TCr | |
| -0.96% | -4.50% | +26.36% | +33.18% | 4.25TCr | |
| -0.20% | -0.77% | +3.74% | +100.60% | 4.07TCr | |
| -0.54% | +2.93% | +9.31% | +50.41% | 3.1TCr | |
| -2.68% | +2.92% | +29.63% | +19.50% | 2.85TCr | |
| +0.05% | -1.64% | -7.28% | -14.06% | 2.43TCr | |
| Average | -0.88% | -1.61% | +52.71% | +121.48% | 3.91TCr | |
| Weighted average by Cap. | +0.11% | -0.86% | +58.72% | +129.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.74Cr 5.99Cr 5.59Cr 5.1Cr 9.61Cr 648.2Cr 9.7Cr 68Cr 26Cr 331.37Cr 25Cr 25Cr 1.06TCr | 5.39Cr 4.79Cr 4.47Cr 4.08Cr 7.69Cr 518.48Cr 7.76Cr 54Cr 21Cr 265.06Cr 20Cr 20Cr 850.66Cr |
| Net income | -15Cr -13Cr -12Cr -11Cr -21Cr -1.44TCr -22Cr -150.08Cr -58Cr -734.92Cr -56Cr -55Cr -2.36TCr | -21Cr -18Cr -17Cr -16Cr -30Cr -1.99TCr -30Cr -208.05Cr -81Cr -1.02TCr -78Cr -76Cr -3.27TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | $10.50 | -6.75% | 22,14,535 |
| 01/26/01 | $11.26 | -5.62% | 28,68,605 |
| 30/26/30 | $11.93 | +1.62% | 9,13,958 |
| 29/26/29 | $11.74 | +0.26% | 5,45,067 |
| 28/26/28 | $11.71 | -0.51% | 7,72,655 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLUE Stock
Select your edition
All financial news and data tailored to specific country editions
